Gainers
- SciSparc Ltd. SPRC shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. SciSparc recently regained compliance with the Nasdaq Minimum Bid Price Notification.
- WiSA Technologies, Inc. WISA shares rose 76.4% to $0.4380 in pre-market trading after falling 40% on Monday. WiSA Technologies announced the pricing of a $4.8 million public offering of Series B convertible redeemable preferred stock and warrants.
- Athersys, Inc. ATHX shares gained 51.5% to $0.1487 in pre-market trading. Athersys extended near-term liquidity with proceeds from warrant inducement and a global ARDS license with Healios to explore strategic alternatives.
- Aurora Mobile Limited JG shares climbed 50.8% to $0.2005 in pre-market trading after gaining 8% on Monday.
- ZW Data Action Technologies Inc. CNET rose 30.8% to $1.23 in pre-market trading after declining 13% on Monday.
- Meiwu Technology Company Limited WNW shares rose 30.4% to $0.12 in pre-market trading after falling 4% on Monday.
- Jaguar Health, Inc. JAGX gained 13.5% to $0.4085 in pre-market trading after gaining more than 12% on Monday.
- Vistagen Therapeutics, Inc. VTGN shares rose 12.6% to $3.57 in pre-market trading after a 13G filing showed Citadel Advisors LLC reported a 5.6% stake in the company.
- AGBA Group Holding Limited AGBA rose 12.2% to $0.55 in pre-market trading.
- Akso Health Group AHG shares jumped 8.6% to $2.01 in pre-market trading. Akso Health Group recently regained compliance with Nasdaq's Minimum Bid Price Requirement.
Losers
- Nuvve Holding Corp. NVVE dipped 33.5% to $0.2599 in pre-market trading after gaining over 9% on Monday.
- NetScout Systems, Inc. NTCT shares fell 23% to $21.24 in pre-market trading after the company reported weak preliminary results for the second quarter and lowered its FY24 guidance.
- Processa Pharmaceuticals, Inc. PCSA shares fell 18.6% to $0.4547 in pre-market trading, after jumping 16% on Monday.
- MingZhu Logistics Holdings Limited YGMZ shares fell 14.5% to $0.5731 in pre-market trading after jumping around 38% on Monday.
- Rani Therapeutics Holdings, Inc. RANI fell 13.5% to $1.90 in pre-market trading after gaining 11% on Monday.
- Ambrx Biopharma Inc. AMAM fell 13.4% to $9.90 in pre-market trading after declining 19% on Monday. Ambrx Biopharma announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic castration-resistant prostate cancer (mCRPC) were made available as part of the 2023 European Society of Medical Oncology Congress 2023 meeting.
- 22nd Century Group, Inc. XXII shares fell 11.9% to $0.4840 in pre-market trading after reporting a proposed public offering.
- XTL Biopharmaceuticals Ltd. XTLB fell 11.8% to $0.7528 in pre-market after dipping around 15% on Monday.
- NuCana plc NCNA shares fell 11.7% to $0.50 in pre-market trading after declining around 12% on Monday. NuCana presented data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023.
- Avinger, Inc. AVGR shares fell 11.2% to $5.71 in pre-market trading, after gaining over 21% on Monday.
Now Read This: Investor Fear Eases Ahead Of Big Earnings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in